Patent ID: 9441222
Filing Date: 2016-09-13
CPC Classification: A61P,C12N,C12Q

Claim Text:
1. A method for preventing, treating, reverting, and/or delaying neo-angiogenesis or a condition or disease associated with neo-angiogenesis in a subject in need thereof by administering to the subject at least one miRNA molecule or a composition comprising said miRNA molecule, wherein said miRNA molecule is selected from the group consisting of: an miRNA molecule from 6 to 30 nucleotides comprising at least 6 of the nucleotides present in seed sequence SEQ ID NO: 377, 378, 379, 380, 381, 114 or 115 and having at least 70% identity with SEQ ID NO: 51, 52, 290-304, 382-395 or 396 (miRNA-9), an miRNA molecule from 6 to 30 nucleotides comprising at least 6 of the nucleotides present in seed sequence SEQ ID NO: 77-80, 82-84, 353 or 354 and having at least 70% identity with SEQ ID NO: 27, 28, 181-204 or 205 (miRNA-574), an miRNA molecule from 6 to 30 nucleotides comprising at least 6 of the nucleotides present in seed sequence SEQ ID NO: 62-69, 71-73, 74, 348, 349 or 350 and having at least 70% identity with SEQ ID NO: 22, 23, 24, 116-176 or 177 (miRNA-7), an miRNA molecule from 6 to 30 nucleotides comprising at least 6 of the nucleotides present in seed sequence SEQ ID NO: 96 or 374 and having at least 70% identity with SEQ ID NO: 48, 234-239 or 240 (miRNA-190b), an miRNA molecule from 6 to 30 nucleotides comprising at least 6 of the nucleotides present in seed sequence SEQ ID NO: 97, 99-110, 375 or 376 and having at least 70% identity with SEQ ID NO: 49, 50, 241-288 or 289 (miRNA-142), and/or a precursor of said miRNA molecule.